UN&UP Receives Its First Phase II Award from the NINDS

 


UN&UP is excited to announce that it has received its first Phase II NIH SBIR award from the NINDS to develop transformative endovascular therapies. Our research partners include key opinion leaders from Washington University, University of Iowa, UC San Diego, University of Florida, and MagCorp.

This is the 9ᵗʰ NIH award UN&UP has received since 2019.

 
Previous
Previous

UN&UP Announces a new NHLBI SBIR Award

Next
Next

UN&UP Announces the Hire of Leah Morrell